Repare Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Repare Therapeutics

09/11/2022 21:48

* Repare Therapeutics Inc  RPTX.OQ  reported quarterly
adjusted
earnings of $1.71​​ per share for the quarter ended in
September. The mean expectation of seven analysts for the
quarter was for a loss of 89 cents per share.
    * Revenue rose 40,383.8% to $112.55 million from a year ago;
analysts expected $1.58 million. 
    * Repare Therapeutics Inc's reported EPS for the quarter was
$1.71​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Repare Therapeutics Inc shares had risen by 22.0% this
quarter and lost 29.8% so far this year.
    * The company reported quarterly net income of $75.46
million.
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $29.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 09:48 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.89          1.71           Beat
 Jun. 30 2022      -0.85          -0.91          Missed
 Mar. 31 2022      -0.86          -0.83          Beat
 Dec. 31 2021      -0.74          -0.70          Beat